China Osteoarthritis Pain Drugs Market Report & Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Osteoarthritis Pain Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Osteoarthritis Pain Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Osteoarthritis Pain Drugs Overall Market Size
2.1 China Osteoarthritis Pain Drugs Market Size: 2021 VS 2027
2.2 China Osteoarthritis Pain Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Osteoarthritis Pain Drugs Sales: 2016-2027

3 Company Landscape
3.1 Top Osteoarthritis Pain Drugs Players in China Market
3.2 Top China Osteoarthritis Pain Drugs Companies Ranked by Revenue
3.3 China Osteoarthritis Pain Drugs Revenue by Companies
3.4 China Osteoarthritis Pain Drugs Sales by Companies
3.5 China Osteoarthritis Pain Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Osteoarthritis Pain Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Osteoarthritis Pain Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteoarthritis Pain Drugs Players in China Market
3.8.1 List of Tier 1 Osteoarthritis Pain Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Osteoarthritis Pain Drugs Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - China Osteoarthritis Pain Drugs Revenue & Forecasts
4.2.1 By Type - China Osteoarthritis Pain Drugs Revenue, 2016-2021
4.2.2 By Type - China Osteoarthritis Pain Drugs Revenue, 2022-2027
4.2.3 By Type - China Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Osteoarthritis Pain Drugs Sales & Forecasts
4.3.1 By Type - China Osteoarthritis Pain Drugs Sales, 2016-2021
4.3.2 By Type - China Osteoarthritis Pain Drugs Sales, 2022-2027
4.3.3 By Type - China Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
4.4 By Type - China Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Osteoarthritis Pain Drugs Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - China Osteoarthritis Pain Drugs Revenue & Forecasts
5.2.1 By Application - China Osteoarthritis Pain Drugs Revenue, 2016-2021
5.2.2 By Application - China Osteoarthritis Pain Drugs Revenue, 2022-2027
5.2.3 By Application - China Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Osteoarthritis Pain Drugs Sales & Forecasts
5.3.1 By Application - China Osteoarthritis Pain Drugs Sales, 2016-2021
5.3.2 By Application - China Osteoarthritis Pain Drugs Sales, 2022-2027
5.3.3 By Application - China Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
5.4 By Application - China Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Pfizer Osteoarthritis Pain Drugs Product Description
6.1.5 Pfizer Recent Developments
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Overview
6.2.3 Bayer Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Bayer Osteoarthritis Pain Drugs Product Description
6.2.5 Bayer Recent Developments
6.3 SK Chemicals
6.3.1 SK Chemicals Corporation Information
6.3.2 SK Chemicals Overview
6.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 SK Chemicals Osteoarthritis Pain Drugs Product Description
6.3.5 SK Chemicals Recent Developments
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Overview
6.4.3 GSK Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 GSK Osteoarthritis Pain Drugs Product Description
6.4.5 GSK Recent Developments
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Overview
6.5.3 Sanofi Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Sanofi Osteoarthritis Pain Drugs Product Description
6.5.5 Sanofi Recent Developments
6.6 Crystal Genomics
6.6.1 Crystal Genomics Corporation Information
6.6.2 Crystal Genomics Overview
6.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Crystal Genomics Osteoarthritis Pain Drugs Product Description
6.6.5 Crystal Genomics Recent Developments
6.7 Johnson & Johnson
6.7.1 Johnson & Johnson Corporation Information
6.7.2 Johnson & Johnson Overview
6.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Product Description
6.7.5 Johnson & Johnson Recent Developments
6.8 Sino Biopharmaceutical
6.8.1 Sino Biopharmaceutical Corporation Information
6.8.2 Sino Biopharmaceutical Overview
6.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
6.8.5 Sino Biopharmaceutical Recent Developments
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Overview
6.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 Haohai Biological Osteoarthritis Pain Drugs Product Description
6.9.5 Haohai Biological Recent Developments
6.10 Zhejiang Chengyi Pharmaceutical
6.10.1 Zhejiang Chengyi Pharmaceutical Corporation Information
6.10.2 Zhejiang Chengyi Pharmaceutical Overview
6.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
6.11 Freda
6.11.1 Freda Corporation Information
6.11.2 Freda Overview
6.11.3 Freda Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.11.4 Freda Osteoarthritis Pain Drugs Product Description
6.11.5 Freda Recent Developments
6.12 Bright Future
6.12.1 Bright Future Corporation Information
6.12.2 Bright Future Overview
6.12.3 Bright Future Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.12.4 Bright Future Osteoarthritis Pain Drugs Product Description
6.12.5 Bright Future Recent Developments
6.13 Jingfeng Pharmaceutical
6.13.1 Jingfeng Pharmaceutical Corporation Information
6.13.2 Jingfeng Pharmaceutical Overview
6.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.13.5 Jingfeng Pharmaceutical Recent Developments
6.14 Chugai Pharmaceutical
6.14.1 Chugai Pharmaceutical Corporation Information
6.14.2 Chugai Pharmaceutical Overview
6.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.14.5 Chugai Pharmaceutical Recent Developments
6.15 Mikasa Seiyaku
6.15.1 Mikasa Seiyaku Corporation Information
6.15.2 Mikasa Seiyaku Overview
6.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Description
6.15.5 Mikasa Seiyaku Recent Developments
6.16 Taisho Pharmaceutical
6.16.1 Taisho Pharmaceutical Corporation Information
6.16.2 Taisho Pharmaceutical Overview
6.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.16.5 Taisho Pharmaceutical Recent Developments
6.17 Seikagaku Corporation
6.17.1 Seikagaku Corporation Corporation Information
6.17.2 Seikagaku Corporation Overview
6.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Product Description
6.17.5 Seikagaku Corporation Recent Developments
6.18 GlaxoSmithKline
6.18.1 GlaxoSmithKline Corporation Information
6.18.2 GlaxoSmithKline Overview
6.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Product Description
6.18.5 GlaxoSmithKline Recent Developments
6.19 Eli Lilly
6.19.1 Eli Lilly Corporation Information
6.19.2 Eli Lilly Overview
6.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.19.4 Eli Lilly Osteoarthritis Pain Drugs Product Description
6.19.5 Eli Lilly Recent Developments
6.20 Novartis
6.20.1 Novartis Corporation Information
6.20.2 Novartis Overview
6.20.3 Novartis Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.20.4 Novartis Osteoarthritis Pain Drugs Product Description
6.20.5 Novartis Recent Developments
6.21 Horizon Pharma
6.21.1 Horizon Pharma Corporation Information
6.21.2 Horizon Pharma Overview
6.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.21.4 Horizon Pharma Osteoarthritis Pain Drugs Product Description
6.21.5 Horizon Pharma Recent Developments
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Overview
6.22.3 Abbott Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.22.4 Abbott Osteoarthritis Pain Drugs Product Description
6.22.5 Abbott Recent Developments
6.23 Mylan
6.23.1 Mylan Corporation Information
6.23.2 Mylan Overview
6.23.3 Mylan Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.23.4 Mylan Osteoarthritis Pain Drugs Product Description
6.23.5 Mylan Recent Developments
6.24 Daiichi Sankyo
6.24.1 Daiichi Sankyo Corporation Information
6.24.2 Daiichi Sankyo Overview
6.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Product Description
6.24.5 Daiichi Sankyo Recent Developments
6.25 TEVA
6.25.1 TEVA Corporation Information
6.25.2 TEVA Overview
6.25.3 TEVA Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.25.4 TEVA Osteoarthritis Pain Drugs Product Description
6.25.5 TEVA Recent Developments
6.26 Almatica Pharma
6.26.1 Almatica Pharma Corporation Information
6.26.2 Almatica Pharma Overview
6.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.26.4 Almatica Pharma Osteoarthritis Pain Drugs Product Description
6.26.5 Almatica Pharma Recent Developments
6.27 Astellas Pharma
6.27.1 Astellas Pharma Corporation Information
6.27.2 Astellas Pharma Overview
6.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.27.4 Astellas Pharma Osteoarthritis Pain Drugs Product Description
6.27.5 Astellas Pharma Recent Developments
6.28 Tide Pharmaceutical
6.28.1 Tide Pharmaceutical Corporation Information
6.28.2 Tide Pharmaceutical Overview
6.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.28.5 Tide Pharmaceutical Recent Developments
6.29 Iroko Pharmaceuticals
6.29.1 Iroko Pharmaceuticals Corporation Information
6.29.2 Iroko Pharmaceuticals Overview
6.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Description
6.29.5 Iroko Pharmaceuticals Recent Developments
6.30 Hengrui Pharmaceutical
6.30.1 Hengrui Pharmaceutical Corporation Information
6.30.2 Hengrui Pharmaceutical Overview
6.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in China Market (2016-2021)
6.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.30.5 Hengrui Pharmaceutical Recent Developments

7 China Osteoarthritis Pain Drugs Production Capacity, Analysis
7.1 China Osteoarthritis Pain Drugs Production Capacity, 2016-2027
7.2 Osteoarthritis Pain Drugs Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Osteoarthritis Pain Drugs Supply Chain Analysis
9.1 Osteoarthritis Pain Drugs Industry Value Chain
9.2 Osteoarthritis Pain Drugs Upstream Market
9.3 Osteoarthritis Pain Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Osteoarthritis Pain Drugs Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer


List of Tables
Table 1. Key Players of Osteoarthritis Pain Drugs in China Market
Table 2. Top Osteoarthritis Pain Drugs Players in China Market, Ranking by Revenue (2019)
Table 3. China Osteoarthritis Pain Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Osteoarthritis Pain Drugs Revenue Share by Companies, 2016-2021
Table 5. China Osteoarthritis Pain Drugs Sales by Companies, (M Dose), 2016-2021
Table 6. China Osteoarthritis Pain Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Osteoarthritis Pain Drugs Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers Osteoarthritis Pain Drugs Product Type
Table 9. List of Tier 1 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral
Table 12. Major Manufacturers of Injection
Table 13. By Type – China Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Osteoarthritis Pain Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Osteoarthritis Pain Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Osteoarthritis Pain Drugs Sales (M Dose), 2016-2021
Table 17. By Type - China Osteoarthritis Pain Drugs Sales (M Dose), 2022-2027
Table 18. By Application – China Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Osteoarthritis Pain Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Osteoarthritis Pain Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Osteoarthritis Pain Drugs Sales (M Dose), 2016-2021
Table 22. By Application - China Osteoarthritis Pain Drugs Sales (M Dose), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Pfizer Osteoarthritis Pain Drugs Product
Table 27. Pfizer Recent Developments
Table 28. Bayer Corporation Information
Table 29. Bayer Description and Major Businesses
Table 30. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Bayer Osteoarthritis Pain Drugs Product
Table 32. Bayer Recent Developments
Table 33. SK Chemicals Corporation Information
Table 34. SK Chemicals Description and Major Businesses
Table 35. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. SK Chemicals Osteoarthritis Pain Drugs Product
Table 37. SK Chemicals Recent Developments
Table 38. GSK Corporation Information
Table 39. GSK Description and Major Businesses
Table 40. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. GSK Osteoarthritis Pain Drugs Product
Table 42. GSK Recent Developments
Table 43. Sanofi Corporation Information
Table 44. Sanofi Description and Major Businesses
Table 45. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Sanofi Osteoarthritis Pain Drugs Product
Table 47. Sanofi Recent Developments
Table 48. Crystal Genomics Corporation Information
Table 49. Crystal Genomics Description and Major Businesses
Table 50. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 52. Crystal Genomics Recent Developments
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Major Businesses
Table 55. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 57. Johnson & Johnson Recent Developments
Table 58. Sino Biopharmaceutical Corporation Information
Table 59. Sino Biopharmaceutical Description and Major Businesses
Table 60. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 61. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 62. Sino Biopharmaceutical Recent Developments
Table 63. Haohai Biological Corporation Information
Table 64. Haohai Biological Description and Major Businesses
Table 65. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 66. Haohai Biological Osteoarthritis Pain Drugs Product
Table 67. Haohai Biological Recent Developments
Table 68. Zhejiang Chengyi Pharmaceutical Corporation Information
Table 69. Zhejiang Chengyi Pharmaceutical Description and Major Businesses
Table 70. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 71. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 72. Zhejiang Chengyi Pharmaceutical Recent Developments
Table 73. Freda Corporation Information
Table 74. Freda Description and Major Businesses
Table 75. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 76. Freda Osteoarthritis Pain Drugs Product
Table 77. Freda Recent Developments
Table 78. Bright Future Corporation Information
Table 79. Bright Future Description and Major Businesses
Table 80. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 81. Bright Future Osteoarthritis Pain Drugs Product
Table 82. Bright Future Recent Developments
Table 83. Jingfeng Pharmaceutical Corporation Information
Table 84. Jingfeng Pharmaceutical Description and Major Businesses
Table 85. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 86. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 87. Jingfeng Pharmaceutical Recent Developments
Table 88. Chugai Pharmaceutical Corporation Information
Table 89. Chugai Pharmaceutical Description and Major Businesses
Table 90. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 91. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 92. Chugai Pharmaceutical Recent Developments
Table 93. Mikasa Seiyaku Corporation Information
Table 94. Mikasa Seiyaku Description and Major Businesses
Table 95. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 96. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 97. Mikasa Seiyaku Recent Developments
Table 98. Taisho Pharmaceutical Corporation Information
Table 99. Taisho Pharmaceutical Description and Major Businesses
Table 100. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 101. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 102. Taisho Pharmaceutical Recent Developments
Table 103. Seikagaku Corporation Corporation Information
Table 104. Seikagaku Corporation Description and Major Businesses
Table 105. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 106. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 107. Seikagaku Corporation Recent Developments
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 111. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 112. GlaxoSmithKline Recent Developments
Table 113. Eli Lilly Corporation Information
Table 114. Eli Lilly Description and Major Businesses
Table 115. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 116. Eli Lilly Osteoarthritis Pain Drugs Product
Table 117. Eli Lilly Recent Developments
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 121. Novartis Osteoarthritis Pain Drugs Product
Table 122. Novartis Recent Developments
Table 123. Horizon Pharma Corporation Information
Table 124. Horizon Pharma Description and Major Businesses
Table 125. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 126. Horizon Pharma Osteoarthritis Pain Drugs Product
Table 127. Horizon Pharma Recent Developments
Table 128. Abbott Corporation Information
Table 129. Abbott Description and Major Businesses
Table 130. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 131. Abbott Osteoarthritis Pain Drugs Product
Table 132. Abbott Recent Developments
Table 133. Mylan Corporation Information
Table 134. Mylan Description and Major Businesses
Table 135. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 136. Mylan Osteoarthritis Pain Drugs Product
Table 137. Mylan Recent Developments
Table 138. Daiichi Sankyo Corporation Information
Table 139. Daiichi Sankyo Description and Major Businesses
Table 140. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 141. Daiichi Sankyo Osteoarthritis Pain Drugs Product
Table 142. Daiichi Sankyo Recent Developments
Table 143. TEVA Corporation Information
Table 144. TEVA Description and Major Businesses
Table 145. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 146. TEVA Osteoarthritis Pain Drugs Product
Table 147. TEVA Recent Developments
Table 148. Almatica Pharma Corporation Information
Table 149. Almatica Pharma Description and Major Businesses
Table 150. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 151. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 152. Almatica Pharma Recent Developments
Table 153. Astellas Pharma Corporation Information
Table 154. Astellas Pharma Description and Major Businesses
Table 155. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 156. Astellas Pharma Osteoarthritis Pain Drugs Product
Table 157. Astellas Pharma Recent Developments
Table 158. Tide Pharmaceutical Corporation Information
Table 159. Tide Pharmaceutical Description and Major Businesses
Table 160. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 161. Tide Pharmaceutical Osteoarthritis Pain Drugs Product
Table 162. Tide Pharmaceutical Recent Developments
Table 163. Iroko Pharmaceuticals Corporation Information
Table 164. Iroko Pharmaceuticals Description and Major Businesses
Table 165. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 166. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 167. Iroko Pharmaceuticals Recent Developments
Table 168. Hengrui Pharmaceutical Corporation Information
Table 169. Hengrui Pharmaceutical Description and Major Businesses
Table 170. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 171. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product
Table 172. Hengrui Pharmaceutical Recent Developments
Table 173. Osteoarthritis Pain Drugs Production Capacity (M Dose) of Key Manufacturers in China Market, 2019-2021 (M Dose)
Table 174. China Osteoarthritis Pain Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 175. Osteoarthritis Pain Drugs Market Opportunities & Trends in China Market
Table 176. Osteoarthritis Pain Drugs Market Drivers in China Market
Table 177. Osteoarthritis Pain Drugs Market Restraints in China Market
Table 178. Osteoarthritis Pain Drugs Raw Materials
Table 179. Osteoarthritis Pain Drugs Raw Materials Suppliers in China Market
Table 180. Typical Osteoarthritis Pain Drugs Downstream
Table 181. Osteoarthritis Pain Drugs Downstream Clients in China Market
Table 182. Osteoarthritis Pain Drugs Distributors and Sales Agents in China Market
List of Figures
Figure 1. Osteoarthritis Pain Drugs Product Picture
Figure 2. Osteoarthritis Pain Drugs Segment by Type
Figure 3. Osteoarthritis Pain Drugs Segment by Application
Figure 4. China Osteoarthritis Pain Drugs Market Overview: 2020
Figure 5. China Osteoarthritis Pain Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Osteoarthritis Pain Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Osteoarthritis Pain Drugs Sales in China Market: 2016-2027 (M Dose)
Figure 8. The Top 3 and 5 Players Market Share by Osteoarthritis Pain Drugs Revenue in 2020
Figure 9. Oral Product Picture
Figure 10. Injection Product Picture
Figure 11. External Product Picture
Figure 12. By Type - China Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
Figure 13. By Type - China Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
Figure 14. By Type - China Osteoarthritis Pain Drugs Price (US$/Dose), 2016-2027
Figure 15. Medical Care
Figure 16. Personal Care
Figure 17. By Application - China Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
Figure 18. By Application - China Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - China Osteoarthritis Pain Drugs Price (US$/Dose), 2016-2027
Figure 20. Pfizer Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Bayer Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. SK Chemicals Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. GSK Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sanofi Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Crystal Genomics Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Johnson & Johnson Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Haohai Biological Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Freda Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Bright Future Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Seikagaku Corporation Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. GlaxoSmithKline Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Eli Lilly Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Horizon Pharma Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Abbott Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Mylan Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Daiichi Sankyo Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. TEVA Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Almatica Pharma Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Astellas Pharma Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure